Facing thousands of state and local civil lawsuits, opioid makers including Teva and Johnson & Johnson are scrambling to ink a deal to escape the multibillion-dollar legal overhang. But civil charges could be the least of the drugmakers’ concerns, with the
read moreThe co-founders of Outcome Health and several former executives have been charged by the Department of Justice (DOJ) in a $1 billion fraud scheme targeting clients, lenders and investors. The DOJ filed the criminal indictment this week, charging Rishi Shah
read moreA Pennsylvania appeals court upheld a 2016 verdict against J&J worth $70 million. The case stems back to a 2013 lawsuit from Andrew Yount and his mother alleging the company’s Risperdal caused him to develop breasts, a condition called gynecomastia. The
read moreXofluza from Roche’s Genentech unit was approved by the FDA for patients over the age of 12, and the company is hoping the label will be expanded to include children. But a new study out of the University of Wisconsin
read moreThe Institute for Clinical and Economic Review (ICER) released the latest iteration of its draft assessment of the cost effectiveness of JAK inhibitors to treat rheumatoid arthritis (RA). AbbVie’s Rinvoq comes off a bit better than it did in an
read moreMore: Manufacturing News of Note: Aurobindo gets two 483s; Catalent to make BeiGene drug Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals